Skip to main content

Table 5 Unadjusted and adjusted analysis for nutrition profiles and liver function tests among adults in intensive care unit

From: Hospital change to mixed lipid emulsion from soybean oil-based lipid emulsion for parenteral nutrition in hospitalized and critically ill adults improves outcomes: a pre–post-comparative study

 

Intralipid*

4-OLE

Unadjusted analysis

Adjusted analysis

p-value

(N = 110)

(N = 337)

p value

Estimate (95% CI)

Total days receiving lipids, median (IQR)

10.0 (6.0–15.0)

9.0 (5.0–19.0)

0.91

2.05 (− 0.64, 4.73)

0.13

Daily lipid dosage (g/kg/day), median (IQR)

0.5 (0.4–0.7)

0.6 (0.4–0.7)

0.08

0.06 (0.01, 0.11)

0.018

Daily calories (calories/kg/day), median (IQR)

21.5 (17.2–27.7)

23.1 (18.7–29.6)

0.08

0.26 (− 0.06, 0.59)

0.11

Daily protein (g/kg/day), median (IQR)

0.8 (0.7–0.9)

0.8 (0.7–1.0)

0.041

0.03 (− 0.01, 0.08)

0.11

Daily dextrose (g/kg/day), median (IQR)

1.4 (1.0–1.8)

1.4 (1.0–1.9)

0.44

0.05 (− 0.07, 0.16)

0.46

Liver function tests, median (IQR)

Delta AST (units/L)

27.0 (8.0–99.0)

27.5 (8.0–99.0)

0.85

45.3 (− 201.1, 291.8)

0.72

Delta ALT (units/L)

26.0 (4.0–78.0)

24.0 (5.0–97.0)

0.79

41.7 (− 60.4, 143.7)

0.42

Delta ALP (international units/L)

56.0 (17.0–153.0)

47.0 (10.0–160.0)

0.78

11.6 (− 28.5, 51.7)

0.57

Delta total bilirubin (mg/dL)

1.1 (0.5–3.2)

1.0 (0.4–2.5)

0.28

− 1.6 (− 2.9, − 0.2)

0.021

  1. We adjusted for age, sex, race, ethnicity, insurance status, cancer, malnutrition, ED admission, and BMI in kg/m2
  2. IQR Interquartile range; 4-OLE SMOFLipid
  3. *Intralipid—(Baxter Inc, Deerfield, IL, USA)